A CONTROLLED-RELEASE COMPOSITION COMPRISING A COMPLEX OF A CLAY MINERAL AND ALPHA ADRENERGIC BLOCKING AGENT FOR ADMINISTRATION

The present invention relates to: a controlled-release composition for oral administration comprising a hydrophilic alpha sympatholytic drug compound or a salt thereof and a complex of clay minerals; and a method for manufacturing the same. A composition of the present invention has a release rate o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SUNG MAN SEO, JAE HWAN KIM, HYUN JONG SHIN, KI MIN ROH, MIN JUN BAEK, IL MO KANG, JU HWAN PARK, DAE DUK KIM, LEE JANGIK IKE, SU YOUNG JUNG
Format: Patent
Sprache:eng ; kor
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to: a controlled-release composition for oral administration comprising a hydrophilic alpha sympatholytic drug compound or a salt thereof and a complex of clay minerals; and a method for manufacturing the same. A composition of the present invention has a release rate of the body which is controlled more than an existing alpha sympatholytic drug compound, thereby being able to prevent side effects due to the rapid increase of a blood drug concentration. 본 발명은 친수성 알파 교감신경 차단제 화합물 또는 그 염;및 점토광물의 복합체를 포함하는, 방출성이 제어된 경구투여용 조성물 및 그 제조 방법에 대한 것이다. 본 발명의 조성물은 기존의 알파 교감신경 차단제 화합물보다 체내 방출 속도가 제어됨으로써 급격한 혈중 약물 농도 증가로 인한 부작용이 방지된다.